Xenograft tissue control for histology

Details for Australian Patent Application No. 2006242224 (hide)

Owner Ventana Medical Systems, Inc.

Inventors Grogan, Thomas M.; Nagle, Ray B.; Hardy, Margaret

Agent Spruson & Ferguson

Pub. Number AU-A-2006242224

PCT Pub. Number WO2006/119265

Priority 60/676,056 29.04.05 US

Filing date 1 May 2006

Wipo publication date 9 November 2006

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119265 Priority application(s): WO2006/119265

24 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242225-Human microRNAs and methods for inhibiting same

2006242219-Combination of dipeptidyl peptidase-IV inhibitor and a cannabinoid CB1 receptor antagonist for the treatment of diabetes and obesity